BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30906734)

  • 1. The Effect of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in 400 Locally Advanced Cervical Carcinoma Patients.
    Kroesen M; Mulder HT; van Holthe JML; Aangeenbrug AA; Mens JWM; van Doorn HC; Paulides MM; Oomen-de Hoop E; Vernhout RM; Lutgens LC; van Rhoon GC; Franckena M
    Front Oncol; 2019; 9():134. PubMed ID: 30906734
    [No Abstract]   [Full Text] [Related]  

  • 2. Confirmation of thermal dose as a predictor of local control in cervical carcinoma patients treated with state-of-the-art radiation therapy and hyperthermia.
    Kroesen M; Mulder HT; van Holthe JML; Aangeenbrug AA; Mens JWM; van Doorn HC; Paulides MM; Oomen-de Hoop E; Vernhout RM; Lutgens LC; van Rhoon GC; Franckena M
    Radiother Oncol; 2019 Nov; 140():150-158. PubMed ID: 31302345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia.
    Franckena M; Fatehi D; de Bruijne M; Canters RA; van Norden Y; Mens JW; van Rhoon GC; van der Zee J
    Eur J Cancer; 2009 Jul; 45(11):1969-78. PubMed ID: 19361982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer.
    van Leeuwen CM; Oei AL; Chin KWTK; Crezee J; Bel A; Westermann AM; Buist MR; Franken NAP; Stalpers LJA; Kok HP
    Radiat Oncol; 2017 Apr; 12(1):75. PubMed ID: 28449703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment of inoperable carcinomas of the uterine cervix with radiotherapy and regional hyperthermia. Results of a phase II trial.
    Dinges S; Harder C; Wurm R; Buchali A; Blohmer J; Gellermann J; Wust P; Randow H; Budach V
    Strahlenther Onkol; 1998 Oct; 174(10):517-21. PubMed ID: 9810319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between thermal dose parameters and the efficacy of definitive chemoradiotherapy plus regional hyperthermia in the treatment of locally advanced cervical cancer: data from a multicentre randomised clinical trial.
    Ohguri T; Harima Y; Imada H; Sakurai H; Ohno T; Hiraki Y; Tuji K; Tanaka M; Terashima H
    Int J Hyperthermia; 2018 Jun; 34(4):461-468. PubMed ID: 28679349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of time interval between radiotherapy and hyperthermia on planned equivalent radiation dose.
    van Leeuwen CM; Crezee J; Oei AL; Franken NAP; Stalpers LJA; Bel A; Kok HP
    Int J Hyperthermia; 2018 Nov; 34(7):901-909. PubMed ID: 29749270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility, SAR Distribution, and Clinical Outcome upon Reirradiation and Deep Hyperthermia Using the Hypercollar3D in Head and Neck Cancer Patients.
    Kroesen M; van Holthe N; Sumser K; Chitu D; Vernhout R; Verduijn G; Franckena M; Hardillo J; van Rhoon G; Paulides M
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency.
    Vasanthan A; Mitsumori M; Park JH; Zhi-Fan Z; Yu-Bin Z; Oliynychenko P; Tatsuzaki H; Tanaka Y; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):145-53. PubMed ID: 15629605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinoma.
    Lutgens L; van der Zee J; Pijls-Johannesma M; De Haas-Kock DF; Buijsen J; Mastrigt GA; Lammering G; De Ruysscher DK; Lambin P
    Cochrane Database Syst Rev; 2010 Jan; (1):CD006377. PubMed ID: 20091593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical thermoradiotherapy: the influence of some prognostic parameters on recurrence-free survival.
    Lesnicar H
    Neoplasma; 1997; 44(1):19-24. PubMed ID: 9201276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy--a phase III study.
    Zolciak-Siwinska A; Piotrkowicz N; Jonska-Gmyrek J; Nicke-Psikuta M; Michalski W; Kawczyńska M; Bijok M; Bujko K
    Radiother Oncol; 2013 Nov; 109(2):194-9. PubMed ID: 23684588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.
    Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
    Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma.
    Algan O; Fosmire H; Hynynen K; Dalkin B; Cui H; Drach G; Stea B; Cassady JR
    Cancer; 2000 Jul; 89(2):399-403. PubMed ID: 10918172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate analysis of prognostic parameters using interstitial thermoradiotherapy (IHT-IRT): tumor and treatment variables predict outcome.
    Seegenschmiedt MH; Martus P; Fietkau R; Iro H; Brady LW; Sauer R
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1049-63. PubMed ID: 8083074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dutch Deep Hyperthermia Trial: results in cervical cancer.
    van der Zee J; González GD
    Int J Hyperthermia; 2002; 18(1):1-12. PubMed ID: 11820462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial.
    Sherar M; Liu FF; Pintilie M; Levin W; Hunt J; Hill R; Hand J; Vernon C; van Rhoon G; van der Zee J; Gonzalez DG; van Dijk J; Whaley J; Machin D
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):371-80. PubMed ID: 9308941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement and analysis of the impact of time-interval, temperature and radiation dose on tumour cell survival and its application in thermoradiotherapy plan evaluation.
    van Leeuwen CM; Oei AL; Ten Cate R; Franken NAP; Bel A; Stalpers LJA; Crezee J; Kok HP
    Int J Hyperthermia; 2018 Feb; 34(1):30-38. PubMed ID: 28540813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological treatment evaluation in thermoradiotherapy: application in cervical cancer patients.
    Kok HP; Herrera TD; Crezee J
    Strahlenther Onkol; 2024 Jun; 200(6):512-522. PubMed ID: 38177701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial.
    Franckena M; Stalpers LJ; Koper PC; Wiggenraad RG; Hoogenraad WJ; van Dijk JD; Wárlám-Rodenhuis CC; Jobsen JJ; van Rhoon GC; van der Zee J
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1176-82. PubMed ID: 17881144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.